Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0136061003
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02239661 | NOVO NORDISK CANADA INC | NIASTASE | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 4.8 MG / VIAL |
Approved | 02347148 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 5 MG / VIAL |
Marketed | 02417138 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 5 MG / VIAL |
Application information
Related information
Contact us
Version 4.0.3